News Roche's Tecentriq approved for UK early access Tecentriq is latest immunotherapy available on the scheme.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Cancer Positive results for Pacific Edge's bladder cancer diagnosti... Cancer diagnostic company Pacific Edge has revealed positive trial results for its Cxbladder Monitor gene expression test.
Views & Analysis Pharma gets social: did digital opinion leaders shape NICE g... Digital Opinion Leaders as activists in healthcare decision making.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
